Influenza/Clinical Risks Groups 2006/2007

From Ganfyd

Jump to: navigation, search
Clinical Risks Groups 2006/7
Clinical Risk Group Examples
Chronic respiratory disease & Asthma that requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations requiring hospital admission
  • Chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema; bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD)
  • Children who have previously been admitted to hospital for lower respiratory tract disease
Chronic heart disease
  • Congenital heart disease
  • Hypertension with cardiac complications
  • Chronic heart failure
  • Individuals requiring regular medication and/or follow-up for ischaemic heart disease
Chronic renal disease
  • Chronic renal failure
  • Nephrotic syndrome
  • Renal transplantation
Chronic liver disease
  • Cirrhosis
  • Biliary Atresia
  • Chronic hepatitis
Diabetes requiring insulin or oral hypoglycaemic drugs
  • Type 1 diabetes
  • Type 2 diabetes requiring oral hypoglycaemic drugs
Immunosuppression
  • Immunusuppression due to disease or treatment
  • Patients undergoing chemotherapy leading to immunosuppression
  • Asplenia or splenic dysfunction
  • HIV infection
  • Individuals treated with or likely to be treated with systemic steroids for more than a month at a dose equivalent to prednisolone 20mgs or more per day (any age) or for children under 20 kgs a dose of 1mg/kg/day

Some immunocompromised patients may have a suboptimal immunological response to the vaccine

Personal tools